Ceftobiprole

From WikiMD.org
Jump to navigation Jump to search

Ceftobiprole

Ceftobiprole (pronounced as sef-toe-BIP-role) is an advanced-generation cephalosporin antibiotic that is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.

Etymology

The term "Ceftobiprole" is derived from "cef-", referring to its class as a cephalosporin antibiotic, and "-biprole", a unique suffix assigned to this specific drug.

Usage

Ceftobiprole is used for the treatment of a variety of bacterial infections, including skin and skin structure infections (SSSIs) and pneumonia. It is especially useful in treating infections caused by MRSA and Pseudomonas aeruginosa, two types of bacteria that are often resistant to other antibiotics.

Mechanism of Action

Ceftobiprole works by inhibiting the synthesis of the bacterial cell wall, leading to cell death. It binds to penicillin-binding proteins (PBPs) on the bacterial cell wall and inhibits the cross-linking of peptidoglycan, a critical component of the bacterial cell wall.

Side Effects

Common side effects of Ceftobiprole include nausea, vomiting, diarrhea, and rash. More serious side effects can include Clostridium difficile-associated diarrhea (CDAD) and allergic reactions.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski